Tempus Pixel & Medical Horizons

Tempus Pixel & Medical Horizons Renew Successful Collaboration with 7-Year Distribution Agreement Extension in Italy

Florence, May 2025 – Medical Horizons and Tempus are proud to announce the renewal of their successful partnership. Under a newly extended seven-year exclusive distribution agreement, Medical Horizons will remain Italy’s premier distributor of the Tempus Pixel Radiology portfolio, including Cardio, Lung, and Breast AI solutions.

This renewal marks a significant milestone in a collaboration rooted in innovation and shared values. Medical Horizons initially began working with Arterys, a pioneering radiology AI startup acquired by Tempus in October 2022, as part of the company’s drive to strengthen its imaging AI capabilities. The longstanding relationship between Medical Horizons and Arterys continued seamlessly after the acquisition, forming the foundation of this new agreement.

A Seamless Transition from Arterys to Tempus Pixel

Medical Horizons’ early collaboration with Arterys’ cardiac, lung, and breast AI tools positioned it as a trusted partner during Tempus’s integration phase. Through close cooperation with Tempus VP Chiranjiv Singh and under the strategic guidance of CEO Guido Osti and Product Manager Rolando Arpi, the company spearheaded key installations of Tempus Pixel solutions across Italy.

Today, Tempus Pixel products are at work in prestigious Italian healthcare centres:

• Gruppo Multimedica, Milan

• Meyer Labs, Florence

• Campus Biomedico, Rome

• Papa Giovanni XXIII, Bergamo

• Emicenter, Neaples

  
  

These implementations leverage AI capabilities to enhance diagnostic accuracy and workflow efficiency:

• Tempus Pixel Cardio provides automated cardiac MR segmentation, 4D flow quantification, chamber volumetry, tissue characterization, and myocardial strain analysis  .

• Tempus Pixel Lung detects, quantifies, and tracks lung nodules across CT scans, complete with automated reporting and malignancy risk stratification  .

• Tempus Pixel Breast enhances screening accuracy by detecting lesions in 2D/3D mammograms, assessing breast density, and enabling longitudinal comparisons  .

About Medical Horizons: a Strategic AI Partner

Medical Horizons is Italy’s leading AI-medical devices company, dedicated to fostering meaningful collaborations with cutting-edge vendors. Its deep clinical experience, strategic investments, and global vision make it a reference point for AI adoption in healthcare.

Medical Horizons stands out not merely as a distributor but as a strategic partner committed to driving AI innovation in medicine. Its investment in transparent collaborations and international expansion, especially in Eastern Europe and the Middle East, underscores its ambition to be more than a reseller.

Guido Osti, CEO of Medical Horizons, commented: “This renewed agreement with Tempus reflects years of shared achievements and our ambition to lead Italy into a new era of AI-enabled diagnostics.”

About Tempus Pixel Radiology

Founded in 2015, Tempus is recognized as one of the world’s leading precision medicine technology companies. With a data library of more than 100 million patient records and a mission to make precision medicine a reality through the power of AI, Tempus applies machine learning to imaging, molecular, clinical, and genomic data to deliver actionable insights at scale.

Tempus Pixel combines advanced deep learning with robust clinical integration, enabling radiologists and clinicians to work faster, smarter, and with greater confidence. The platform includes:

• Cardio AI: Fully automated cardiac MRI post-processing, including chamber segmentation, myocardial strain, tissue characterization, and 4D flow analysis.

• Lung AI: Detection, quantification, and tracking of pulmonary nodules with longitudinal comparison and malignancy risk scoring.

• Breast AI: AI-powered lesion detection in 2D and 3D mammography, density assessment, and multi-study comparisons.

Already deployed in over 100 leading health systems, Tempus Pixel has processed more than 1.3 billion medical images, representing one of the largest radiology AI deployments in the world.